[Prevention of tuberculosis in medically high-risked patients].
Sasaki
Yuka
Y
Toyota
Emiko
E
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D015658:HIV Infections / Q000150:complications; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab; D055985:Latent Tuberculosis / Q000188:drug therapy / Q000517:prevention & control; D006435:Renal Dialysis / Q000009:adverse effects; D012306:Risk; D012307:Risk Factors; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab